🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The SHAPERS study is a multicentre, open-label, randomised, pragmatic clini...
Status
Recruiting
Location
ZAS Antwerpen
Start Date
2024-02-07
Trial ID
NCT06052332
Patients with obstruction are associated with worse oncologic outcomes comp...
Status
Recruiting
Location
Beijing Chaoyang Hospital, Capital Medical University
Start Date
2021-12-12
Trial ID
NCT05202314
Treatments Being Tested
The goal of this open-label randomized, multicenter, comparative phase II t...
Status
Recruiting
Location
Institut de Cancérologie de l'Ouest
Start Date
2024-07-23
Trial ID
NCT06333314
Treatments Being Tested
This is an early phase I, single-arm, open-label clinical study designed to...
Status
Recruiting
Location
Biogenea Pharmaeuticals Ltd
Start Date
2026-02-02
Trial ID
NCT07328087
Treatments Being Tested
A Phase 2, Multicenter, Open-Label Study of DKN-01 in Combination with Tisl...
Status
Terminated
Location
Mayo Clinic Cancer Center
Start Date
2020-07-29
Trial ID
NCT04363801
To explore the efficacy and safety of stereotactic body radiation therapy (...
Status
Recruiting
Location
Sixth Affiliated Hospital, Sun Yat-sen University
Start Date
2025-04-10
Trial ID
NCT06794086
Treatments Being Tested
Drugs used in chemotherapy, such as oxaliplatin, leucovorin, fluorouracil, ...
Status
Terminated
Location
Southwest Oncology Group
Start Date
2004-04
Trial ID
NCT00070122
This program is to provide zolbetuximab to people with stomach cancer or ga...
Status
Available
Location
Site US10001
Start Date
TBD
Trial ID
NCT06048081
Treatments Being Tested
This is an open-label, dose-escalation and dose-expansion phase Ib/IIa clin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07680569
Treatments Being Tested
This phase I trial studies the side effects and best dose of papaverine (PP...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-04-07
Trial ID
NCT06834126